Home Medicine Guidelines on CMV congenital infection
Article
Licensed
Unlicensed Requires Authentication

Guidelines on CMV congenital infection

  • Oriol Coll , Guillaume Benoist , Yves Ville , Leonard E. Weisman , Francesc Botet , the WAPM Perinatal Infections Working Group: Maurizio M. Anceschi , Anne Greenough , Ronald S. Gibbs and Xavier Carbonell-Estrany (coordinator)
Published/Copyright: August 13, 2009
Journal of Perinatal Medicine
From the journal Volume 37 Issue 5

Abstract

Congenital cytomegalovirus (CMV) infection occurs in 0.6–0.7% of all newborns and is the most prevalent infection-related cause of congenital neurological handicap. Vertical transmission occurs in around 30% of cases, but the fetus is not always affected. Symptomatic newborns at birth have a much higher risk of suffering severe neurological sequelae. Detection of specific IgG and IgM and IgG avidity seem to be the most reliable tests to identify a primary infection but interpretation in a clinical context may be difficult. If a seroconversion is documented or a fetal infection is suspected by ultrasound markers, an amniocentesis should be performed to confirm a vertical transmission. In the absence of a confirmed fetal infection with fetal structural anomalies, a pregnancy termination should be discouraged. Fetal prognosis is mainly correlated to the presence of brain damage. Despite promising results with the use of antiviral drugs and CMV hyperimmune globulin (HIG), results have to be interpreted with caution. Pregnant women should not be systematically tested for CMV during pregnancy. Managing CMV screening should be restricted to pregnancies where a primary infection is suspected or among women at high risk. The magnitude of congenital CMV disease and the value of interventions to prevent its transmission or to decrease the sequelae need to be established before implementing public health interventions. In this paper, aspects of CMV infection in the pregnant woman and her infant are reviewed.


Corresponding author: Oriol Coll, MD, PhD Department of Maternal-Fetal Medicine Institut Clínic de Ginecologia, Obstetrícia i Neonatologia Hospital Clinic, University of Barcelona Barcelona Spain Tel.: +34-93.227.54.00 Fax: +34-93.227.56.05

Published Online: 2009-08-13
Published in Print: 2009-09-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Recommendations and guidelines for perinatal practice
  2. Guidelines on CMV congenital infection
  3. Minireviews
  4. Towards new diagnostic criteria for diagnosing GDM – the HAPO study
  5. Surveillance during labour
  6. Limit of viability in Japan: ethical consideration
  7. Review article
  8. Outpatient induction – how safe
  9. Original articles – Obstetrics
  10. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus
  11. A randomized trial of cerclage vs. 17 α-hydroxyprogesterone caproate for treatment of short cervix
  12. Umbilical cord insertion site in early gestation and development of placenta
  13. Inappropriate use of vancomycin for preventing perinatal group B streptococcal (GBS) disease in laboring patients
  14. Vitamin D receptor genotype BB is associated with higher serum osteocalcin in first pregnancy
  15. Arylsulphatase A activity and sulphatide concentration in placenta, membranes and cord after delivery
  16. Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-amniotic infection/inflammation
  17. Long chain polyunsaturated fatty acids in mothers and term babies
  18. Body mass index, Bishop score, and sonographic measurement of the cervical length as predictors of successful labor induction in twin gestations
  19. Original articles – Fetus
  20. Coiling characteristics of umbilical cords in breech vs. vertex presentation
  21. Fetal short time variation during labor: a non-invasive alternative to fetal scalp pH measurements?
  22. Prenatal diagnosis and postnatal management of meconium peritonitis
  23. When uncertainty generates more anxiety than severity: the prenatal experience with cystic adenomatoid malformation of the lung
  24. Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome
  25. Original articles – Newborn
  26. Nicotine affects the expression of brain-derived neurotrophic factor mRNA and protein in the hippocampus of hypoxic newborn piglets
  27. Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome
  28. Letters to the Editor
  29. Use and abuse of cesarean section – a transatlantic evaluation
  30. Elective cesarean delivery at 38 weeks' gestation: Is the timing too early?
  31. Grasping activity in utero: a significant indicator of fetal behavior (The role of the grasping reflex in fetal ethology)
  32. Reply
  33. Prevention of intrauterine growth restriction: are there no effective methods available?
  34. Obituary
  35. The death of Prof. Albert Huch
  36. Congress calendar
  37. Congress Calendar
  38. Erratum
  39. Hematological profile of Korean very low birth weight infants
Downloaded on 17.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2009.127/html
Scroll to top button